Pesticides Plus Gene Variant Increase Parkinson’s Risk

by U.S. Medicine

August 5, 2014

LOS ANGELES – Exposure to pesticides may increase the risk of Parkinson’s disease, and certain gene variants may make some people even more susceptible to the disease, according to a new study.

The research, published recently in the journal Neurology, indicates that specific pesticides inhibiting aldehyde dehydrogenase (ALDH) are linked to an increased risk of Parkinson’s disease. The enzyme helps detoxify substances in cells and has a role in metabolism of alcohol, the authors note.1

In addition, people with a variant of the ALDH2 gene were two to five times more likely to develop Parkinson’s disease with exposure to these pesticides than people who did not have that gene variant, the report pointed out.

“These results show that ALDH inhibition appears to be an important mechanism through which pesticides may contribute to the development of Parkinson’s disease,” said study author Jeff M. Bronstein, MD, PhD, of the Los Angeles VAMC and the David Geffen School of Medicine at UCLA. “Understanding this mechanism may reveal several potential targets for preventing the disease from occurring or reducing its progression.”

For the study, researchers focused on 360 Parkinson’s disease patients in three rural California counties, comparing them to 816 people in the area who did not have the disease. Participants’ exposure to pesticides at work and at home was measured using a geographic computer model based on information from the California Department of Pesticide Regulation.

Using a test to identify which pesticides inhibited ALDH, the researchers determined that the 11 pesticides that inhibited ALDH, all used in farming, fell into four structural classes — dithiocarbamates, imidazoles, dicarboxymides and organochlorides.

Study results found that exposure to an ALDH-inhibiting pesticide at both the workplace and at home was associated with increased risks of developing Parkinson’s disease, ranging from 65% for the pesticide benomyl to six times the risk for the pesticide dieldrin. In fact, those exposed to three or more of the pesticides at both work and home were 3.5 times more likely to develop Parkinson’s disease as those who were not exposed.

The relationship between the gene variant and Parkinson’s only appeared when people had been exposed to the pesticides, however.

“In other words, having this gene variant alone does not make you more likely to develop Parkinson’s,” he said. “Parkinson’s is a disease that in many cases may require both genetics and environmental factors to arise.”

1 Fitzmaurice AG, Rhodes SL, Cockburn M, Ritz B, Bronstein JM. Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson’s disease. Neurology. 2014 Feb 4;82(5):419-26. doi: 10.1212/WNL.0000000000000083. PubMed PMID: 24491970; PubMed Central PMCID: PMC3917685.

 


Related Articles

Veteran nephrologist labors to improve ESRD treatment at VA

When Terrence O’Neil, MD, retired as chief of nephrology at the James H. Quillen VAMC in Johnson City in December 2016, he left in his wake decades of work treating kidney disease—nearly 35 years in the Air Force and DoD, plus 11 more at VA.

Committee approves bill to provide agent orange benefits to ‘blue water’ vets

A long sought-after bill that would make it easier for Blue Water Navy veterans to receive Agent Orange benefits has been passed by a key House of Representatives committee.


U.S. Medicine Recommends


More From department of defense dod

Department of Defense (DoD)

DoD acknowledges its medical adverse event reporting is ‘unreliable’

The process for tracking the DoD’s most serious adverse medical events is “fragmented, impeding the Defense Health Agency’s (DHA) ability to ensure that it has received complete information,” according to a new review.

Department of Defense (DoD)

Automation Speeds Results and Increases Accuracy for Point-of-Care Testing at Walter Reed NMMC

With a long history of point of care testing at both of its predecessor organizations, the Walter Reed National Military Medical Center (WRNMMC) laboratory services staff were keenly aware of the advantages of using portable testing devices to obtain rapid patient assessments.

Department of Defense (DoD)

High Rate of Pectoralis Tears Among Deployed Servicemembers Lifting Weights

Lifting weights is one way servicemembers keep in peak physical condition during deployment.

Department of Defense (DoD)

DoD Study Finds That Type 2 Diabetes Increases Breast Cancer Mortality

Having Type 2 diabetes mellitus (DM-2) increases mortality risk in breast cancer patients, regardless of whether diabetes was diagnosed before or after breast cancer, according to a recent study.

Department of Defense (DoD)

Now Hear This: Otolaryngologist Leads Effort to Prevent Auditory Issues

Among those who are exposed to combat, it’s the weapons fire that does it. In the Navy, it’s the noise levels in engine rooms and on the decks of carriers.

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up